Executive Search Success Story: Scaling Commercial Leadership for a Neurovascular Device Manufacturer

How JRG Partners executed a highly confidential, multi-role North American executive search strategy that equipped a rapidly growing neurovascular medical device manufacturer with the specialized commercial, clinical, and regulatory leadership required to accelerate growth, accelerate physician adoption, and drive market penetration across key territories.

The Challenge

A rapidly growing neurovascular medical device manufacturer was experiencing increased demand for its specialized portfolio of stroke intervention, aneurysm treatment, thrombectomy, and embolization technologies. Following a series of vital product launches and expanded commercialization efforts, executive leadership identified several critical operational and structural challenges:

• Increased competition within the highly specialized neurovascular device market
• Growing procurement and partnership demands from hospitals, health systems, and academic medical centers
• The strategic requirement for expansion into new domestic and international markets
• Regulatory complexities associated with high-stakes new product approvals
• Pressing leadership-succession concerns within core commercial and clinical functions
• An acute need for executives capable of scaling large-scale operations while maintaining rapid pace-of-innovation standards
• Compounding pressure to accelerate physician adoption and territory market penetration

The Board of Directors and CEO determined that multiple strategic leadership hires would be required to support the company’s next phase of growth. The confidential mandate covered a VP Sales, VP Marketing, VP Clinical Affairs, VP Regulatory Affairs, Director of Market Access, Director of Commercial Operations, and Regional Sales Directors. The company required an executive search partner with deep sector expertise, access to passive talent, and a proven ability to recruit leaders capable of driving commercial growth within highly specialized medical device markets.

Why They Chose JRG Partners

Deep Neurovascular Device Industry Expertise

Unlike generalist recruiting firms, JRG Partners maintains dedicated practices focused explicitly on medical devices, neurovascular technologies, cardiovascular devices, clinical affairs, regulatory affairs, and healthcare leadership. Our consultants possess an intimate operational understanding of physician engagement, product adoption dynamics, reimbursement strategy, clinical evidence generation, and regulatory compliance.

Access to Passive Medical Device Leaders

Many of the strongest neurovascular executives are fully employed and not actively pursuing new opportunities through standard avenues. JRG Partners leveraged extensive industry relationships, proprietary research, and targeted market intelligence to identify and attract proven leaders directly from neurovascular, cardiovascular, and interventional medical device organizations.

Confidential Search Execution

Because several components of the search involved sensitive succession planning and internal organizational restructuring, discretion was mandatory. JRG Partners conducted highly confidential searches that successfully protected the client’s marketplace reputation while ensuring total operational continuity.

True Nationwide Reach

Securing world-class commercial and clinical direction required an unconstrained search across North America’s primary medical innovation clusters. JRG Partners successfully targeted, engaged, and delivered elite talent distributed across major manufacturing and clinical markets, including Minneapolis, Boston, San Diego, Irvine, Chicago, Atlanta, Dallas, Philadelphia, Houston, and San Francisco.

Our Executive Search Strategy

Phase 1 — Leadership & Strategic Assessment

Our consultants worked closely with the CEO, Board members, and HR leadership to thoroughly assess current leadership capabilities, commercial-growth objectives, clinical-strategy initiatives, regulatory requirements, market-expansion plans, succession-planning concerns, and cultural-alignment requirements. Rather than recruiting against static, legacy job templates, we developed executive profiles dynamically aligned with the company’s long-term growth strategy.

Phase 2 — Advanced Neurovascular Talent Mapping

JRG Partners conducted an extensive market-mapping initiative covering neurovascular device manufacturers, stroke-intervention companies, cardiovascular device organizations, interventional radiology companies, neurosurgical technology providers, publicly traded medical device companies, and private equity-backed device manufacturers. More than 450 executive profiles were systematically identified and evaluated across North America.

Phase 3 — Targeted Executive Engagement

Using a research-driven, discreet outreach framework, our consultants directly engaged leaders with a demonstrated history of success in neurovascular device commercialization, clinical affairs leadership, regulatory strategy, market-access initiatives, physician engagement, product-launch execution, sales-force development, and revenue-growth acceleration. Only candidates demonstrating measurable business impact and leadership excellence advanced.

Phase 4 — Rigorous Evaluation & Selection

Each finalist underwent a comprehensive evaluation covering strategic leadership capability, medical device expertise, commercial-execution success, clinical and regulatory knowledge, team-building effectiveness, change-management experience, cultural alignment, and long-term retention potential.

Key Outcomes

• 450+ targeted neurovascular, stroke-intervention, and interventional radiology executive profiles mapped across primary United States medical device corridors.
• Successfully placed and integrated seven core leadership roles spanning sales, marketing, clinical affairs, regulatory strategy, and commercial operations within 12 months.
• Expanded physician adoption and product utilization metrics by installing a marketing and clinical leadership tier built for advanced clinical evidence translation.
• De-risked global regulatory pathways and improved collaboration with regulatory agencies via newly placed regulatory executives fluent in device approvals.
• Protected corporate reputation and preserved internal organizational stability during sensitive restructuring components by executing strict, confidential executive searches.
• Restored Board and investor confidence by resolving key succession risks and providing a scalable management infrastructure ready for domestic and international expansions.